Old Web
English
Sign In
Acemap
>
authorDetail
>
Nobutaka Yagi
Nobutaka Yagi
Boehringer Ingelheim
Medicine
Internal medicine
Adverse effect
Cardiology
Prospective cohort study
3
Papers
31
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety, Pharmacokinetics and Pharmacodynamics of BI 655064 in Phase 1 Clinical Trials in Healthy Chinese and Japanese Subjects.
2020
British Journal of Clinical Pharmacology
Yasuhiro Tsuda
Christine Grimaldi
Fenglei Huang
Ewald Benediktus
Nobutaka Yagi
Steven J. Padula
In-Jin Jang
Jürgen Steffgen
Show All
Source
Cite
Save
Citations (0)
Safety and efficacy of nintedanib (BIBF 1120) plus pemetrexed in Japanese patients with advanced or recurrent non-small cell lung cancer (NSCLC): A phase I study.
2017
Journal of Clinical Oncology
Haruko Daga
Koji Takeda
Hideaki Okada
Masaki Miyazaki
Shinya Ueda
Hiroyasu Kaneda
Isamu Okamoto
Kiyotaka Yoh
Koichi Goto
Koichi Konishi
Akiko Sarashina
Nobutaka Yagi
Kiyomi Mera
Rolf Kaiser
Kazuhiko Nakagawa
Show All
Source
Cite
Save
Citations (9)
Post-marketing surveillance on the long-term use of dabigatran in Japanese patients with nonvalvular atrial fibrillation: Preliminary report of the J-dabigatran surveillance.
2016
Journal of Arrhythmia
Hiroshi Inoue
Shinichiro Uchiyama
Hirotsugu Atarashi
Ken Okumura
Yukihiro Koretsune
Masahiro Yasaka
Takeshi Yamashita
Makiko Ohnishi
Nobutaka Yagi
Taku Fukaya
Show All
Source
Cite
Save
Citations (22)
1